NHS Cornwall and Isles of Scilly has followed guidance from the Information Commissioner and adopted the healthcare publication scheme.
The scheme helps people access information about us, the decisions we make and how we spend public money.
The pages below will provide you with information on:
- our policies and procedures
- what our priorities are
- what we spend and how we spend it
- what we do
- who we are
Most of the information we produce is available on our website. However, some may be in hard copy only. You can also check if the information you are looking for is in our disclosure log. The disclosure log contains responses to all the freedom of information requests we have received.
Prescribing rebate scheme
NHS Cornwall and Isles of Scilly has a policy to agree and consider future prescribing rebates. The arrangements for the drugs are listed below. Information correct as of 14 April 2022.
Attention deficit hyperactivity disorder
Product: Xaggitin
Company: Ethypharm.
Type: For use in the treatment of attention deficit hyperactivity disorder (ADHD).
Start date: 1 August 2017.
End date: Rolling.
Aligned to PrescQIPP: Yes.
Anti-psychotic medicine
Product: Quetiapine Biquelle
Company: Aspire Pharma Limited.
Type: Atypical anti-psychotic medicine.
Start date: 1 April 2022.
End date: 31 March 2023.
Aligned to PrescQIPP: Yes.
Product: Zaluron XL (Quetiapine XL)
Company: Fontus Health Limited.
Type: Anti-psychotic medicine.
Start date: 1 August 2019.
End date: 30 July 2024.
Aligned to PrescQIPP: Yes.
Emollient for eczema
Product: Balneum
Company: Almirall Limited.
Type: Emollient for eczema.
Start date: 23 June 2020.
End date: 22 June 2022.
Aligned to PrescQIPP: Yes.
Inhalers
Product: Clenil Modulite
Company: Chiesi Limited.
Type: Inhaler.
Start date: 1 August 2021.
End date: 31 July 2023.
Aligned to PrescQIPP: Yes.
Product: Fostair NEXThaler
Company: Chiesi Limited.
Type: Inhaler.
Start date: 1 May 2021.
End date: 30 April 2023.
Aligned to PrescQIPP: Yes.
Product: Fostair pMDI
Company: Chiesi Limited.
Type: Inhaler.
Start date: 1 August 2021.
End date: 31 July 2023.
Aligned to PrescQIPP: Yes.
Product: Sereflo
Company: CIPLA.
Type: Inhaler.
Start date: 1 August 2021.
End date: 31 July 2023.
Aligned to PrescQIPP: Yes.
Insulin
Product: Aprida
Company: Aventis Pharma Limited trading as Sanofi.
Type: Insulin.
Start date: 1 April 2022.
End date: 31 March 2023.
Aligned to PrescQIPP: Yes.
Product: Insuman
Company: Aventis Pharma Limited trading as Sanofi.
Type: Insulin.
Start date: 1 April 2022.
End date: 31 March 2023.
Aligned to PrescQIPP: Yes.
Product: Lispro
Company: Aventis Pharma Limited trading as Sanofi.
Type: Insulin.
Start date: 1 April 2020.
End date: 30 September 2021.
Aligned to PrescQIPP: Yes.
Pain relief
Product: Fencino
Company: DS Ashbourne Limited (Part of the Ethypharm Group).
Type: Pain relief patch.
Start date: 1 April 2016.
End date: Rolling.
Aligned to PrescQIPP: Yes.
Parkinson’s
Product: Pipexus
Company: Ethypharm.
Type: For use in the treatment for Parkinson’s.
Start date: 1 July 2018.
End date: Rolling.
Aligned to PrescQIPP: Yes.
Prostate cancer
Product: Firmagon (degarelix)
Company: Ferring Pharmaceuticals.
Type: For use in the treatment for prostate cancer.
Start date: 1 September 2019.
End date: 31 December 2021.
Aligned to PrescQIPP: Yes.
Page last reviewed: 28 July, 2022